KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Tax Rate (2017 - 2025)

Historic Tax Rate for Acadia Pharmaceuticals (ACAD) over the last 9 years, with Q3 2025 value amounting to 60.99%.

  • Acadia Pharmaceuticals' Tax Rate fell 765500.0% to 60.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.56%, marking a year-over-year decrease of 14700.0%. This contributed to the annual value of 12.25% for FY2024, which is 324400.0% up from last year.
  • Acadia Pharmaceuticals' Tax Rate amounted to 60.99% in Q3 2025, which was down 765500.0% from 33.68% recorded in Q2 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Tax Rate peaked at 82.44% during Q2 2023, and registered a low of 60.99% during Q3 2025.
  • Moreover, its 5-year median value for Tax Rate was 0.03% (2021), whereas its average is 5.39%.
  • Its Tax Rate has fluctuated over the past 5 years, first surged by 837600bps in 2023, then plummeted by -765500bps in 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Tax Rate (Quarter) stood at 0.44% in 2021, then tumbled by -362bps to 2.03% in 2022, then tumbled by -648bps to 15.22% in 2023, then surged by 171bps to 10.76% in 2024, then crashed by -667bps to 60.99% in 2025.
  • Its last three reported values are 60.99% in Q3 2025, 33.68% for Q2 2025, and 31.65% during Q1 2025.